Adenomatoid tumors can be found in a widespread age of people ranging from 18 to 79 years old.

This asymptomatic nature is because a majority of adenomatoid tumors grow silently and are sometimes dormant without causing any pain.

L1 cell adhesion molecule (L1CAM), a marker of NF-kB pathway activation, has been shown to be expressed in adenomatoid tumors (and negative in other benign mesothelial tissues and mesothelioma).

[10] Adenomatoid tumors of the female and male genital tract are characterized by somatic missense mutations in the TRAF7 gene, which leads to aberrant NF-kB pathway activation.

Unlike some malignant mesotheliomas, adenomatoid tumors do not harbor CDKN2A deleterious mutations.

Dynamic contrast enhanced MRI can differentiate tumors from disorders in the testicular region.

This specific characteristic in adenomatoid tumors is variable and can determine whether or not ultrasound is the right technique for the job.

[12] If located in the testes region, removal of the tumor must be handled with great care to prevent damage to testosterone production and keep the patient fertile.